A 60-year-old with HFrEF (EF 30%) on maximally tolerated carvedilol and sacubitril/valsartan presents for optimization. eGFR 65 mL/min/1.73 m², K⁺ 4.4...

Question

A 60-year-old with HFrEF (EF 30%) on maximally tolerated carvedilol and sacubitril/valsartan presents for optimization. eGFR 65 mL/min/1.73 m², K⁺ 4.4 mEq/L; no diabetes. What additional therapy reduces mortality and HF hospitalization independent of diabetes?

Accepted Answer

Dapagliflozin

Answer

Hydralazine-isosorbide dinitrate

Answer

Ivabradine

Answer

Mineralocorticoid receptor antagonist

Answer

Digoxin

us-abim MCQ (SBA): Heart Failure with Reduced Ejection Fraction

A 60-year-old with HFrEF (EF 30%) on maximally tolerated carvedilol and sacubitril/valsartan presents for optimization. eGFR 65 mL/min/1.73 m², K⁺ 4.4 mEq/L; no diabetes. What additional therapy reduces mortality and HF hospitalization independent of diabetes?